These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7637023)

  • 1. Receptor binding site-deleted foot-and-mouth disease (FMD) virus protects cattle from FMD.
    McKenna TS; Lubroth J; Rieder E; Baxt B; Mason PW
    J Virol; 1995 Sep; 69(9):5787-90. PubMed ID: 7637023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategy for producing new foot-and-mouth disease vaccines that display complex epitopes.
    McKenna TS; Rieder E; Lubroth J; Burrage T; Baxt B; Mason PW
    J Biotechnol; 1996 Jan; 44(1-3):83-9. PubMed ID: 8717390
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propagation of an attenuated virus by design: engineering a novel receptor for a noninfectious foot-and-mouth disease virus.
    Rieder E; Berinstein A; Baxt B; Kang A; Mason PW
    Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10428-33. PubMed ID: 8816817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A large-scale evaluation of peptide vaccines against foot-and-mouth disease: lack of solid protection in cattle and isolation of escape mutants.
    Taboga O; Tami C; Carrillo E; Núñez JI; Rodríguez A; Saíz JC; Blanco E; Valero ML; Roig X; Camarero JA; Andreu D; Mateu MG; Giralt E; Domingo E; Sobrino F; Palma EL
    J Virol; 1997 Apr; 71(4):2606-14. PubMed ID: 9060612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmid DNA encoding replicating foot-and-mouth disease virus genomes induces antiviral immune responses in swine.
    Ward G; Rieder E; Mason PW
    J Virol; 1997 Oct; 71(10):7442-7. PubMed ID: 9311823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection of cattle and swine against foot-and-mouth disease, using biosynthetic peptide vaccines.
    Morgan DO; Moore DM
    Am J Vet Res; 1990 Jan; 51(1):40-5. PubMed ID: 2154148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.
    Grubman MJ
    Biologicals; 2005 Dec; 33(4):227-34. PubMed ID: 16289996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marker vaccine potential of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion.
    Fowler VL; Knowles NJ; Paton DJ; Barnett PV
    Vaccine; 2010 Apr; 28(19):3428-34. PubMed ID: 20199761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-response evaluation of a genetically engineered foot-and-mouth disease virus polypeptide immunogen in cattle.
    McKercher PD; Moore DM; Morgan DO; Robertson BH; Callis JJ; Kleid DG; Shire SJ; Yansura DG; Dowbenko D; Small B
    Am J Vet Res; 1985 Mar; 46(3):587-90. PubMed ID: 2986495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus.
    Chinsangaram J; Mason PW; Grubman MJ
    Vaccine; 1998 Oct; 16(16):1516-22. PubMed ID: 9711798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of capsid protein VP1 of the viruses used for the production and challenge of foot-and-mouth disease vaccines in Spain.
    González M; Mateu MG; Martínez MA; Carrillo C; Sobrino F
    Vaccine; 1992; 10(11):731-4. PubMed ID: 1279905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cell attachment site on foot-and-mouth disease virus includes the amino acid sequence RGD (arginine-glycine-aspartic acid).
    Fox G; Parry NR; Barnett PV; McGinn B; Rowlands DJ; Brown F
    J Gen Virol; 1989 Mar; 70 ( Pt 3)():625-37. PubMed ID: 2543752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a Fiber-Modified Adenovirus Vector Vaccine against Foot-and-Mouth Disease in Cattle.
    Medina GN; Montiel N; Diaz-San Segundo F; Sturza D; Ramirez-Medina E; Grubman MJ; de los Santos T
    Clin Vaccine Immunol; 2015 Nov; 23(2):125-36. PubMed ID: 26607309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recognition of foot-and-mouth disease virus and its capsid protein VP1 by bovine peripheral T lymphocytes.
    Garcia-Valcarcel M; Doel T; Collen T; Ryan M; Parkhouse RM
    J Gen Virol; 1996 Apr; 77 ( Pt 4)():727-35. PubMed ID: 8627261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate.
    Mason PW; Piccone ME; Mckenna TS; Chinsangaram J; Grubman MJ
    Virology; 1997 Jan; 227(1):96-102. PubMed ID: 9007062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modified-live infectious bovine rhinotracheitis virus (IBRV) vaccine expressing foot-and-mouth disease virus (FMDV) capsid protein epitopes on surface of hybrid virus particles.
    Kit S; Kit M; DiMarchi R; Little S; Gale C
    Adv Exp Med Biol; 1991; 303():211-20. PubMed ID: 1725233
    [No Abstract]   [Full Text] [Related]  

  • 17. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease.
    Dunn CS; Samuel AR; Pullen LA; Anderson J
    Virology; 1998 Jul; 247(1):51-61. PubMed ID: 9683571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of DNA vaccines for foot-and-mouth disease, evaluation of vaccines encoding replicating and non-replicating nucleic acids in swine.
    Beard C; Ward G; Rieder E; Chinsangaram J; Grubman MJ; Mason PW
    J Biotechnol; 1999 Aug; 73(2-3):243-9. PubMed ID: 10486933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Construction and evaluation of an attenuated vaccine for foot-and-mouth disease: difficulty adapting the leader proteinase-deleted strategy to the serotype O1 virus.
    Almeida MR; Rieder E; Chinsangaram J; Ward G; Beard C; Grubman MJ; Mason PW
    Virus Res; 1998 May; 55(1):49-60. PubMed ID: 9712511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RGD sequence of foot-and-mouth disease virus is essential for infecting cells via the natural receptor but can be bypassed by an antibody-dependent enhancement pathway.
    Mason PW; Rieder E; Baxt B
    Proc Natl Acad Sci U S A; 1994 Mar; 91(5):1932-6. PubMed ID: 8127909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.